News & Events CTI Opens São Paulo, Brazil Office

CTI Opens São Paulo, Brazil Office

July 22, 2014

CTI Clinical Trial and Consulting Services Opens São Paulo, Brazil Office 

FOR IMMEDIATE RELEASE [Cincinnati, OH ~ July 22, 2014]

CTI Clinical Trial and Consulting Services (CTI), an international, privately held, full-service contract research organization announces that it has opened an office in São Paulo, Brazil.  The office is opened through the wholly-owned subsidiary, CTI Clinical Brasil Serviços de Pesquisas Clínicas LTDA.

“We have been working on behalf of our pharmaceutical and biotechnology clients in the Latin America region for a number of years, and we believe that the region is one of the most important and fastest growing,” according to Patrick Earley, Vice President, International. “São Paulo, the largest city in Brazil and the largest city in the southern hemisphere, is key for our global expansion. Latin America’s immense population allows for a vast pool of potential trial patients and access to some of the top medical centers and universities in the world.”

With offices in North America, Europe, and South America, CTI has been working for over fifteen years in the drug development industry, specializing in clinical research programs involving critically ill patient populations.

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is an innovative, international drug and device development organization that delivers a full spectrum of clinical trial and consulting services from bench to commercialization with a focus on immunology and a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology and startup firms with clinical and disease area expertise from a unique mix of academic, medical and industry specialists; rich intellectual capital in transplantation, immunology, infectious diseases, hematology, cardiology, nephrology, hepatology, regenerative medicine and rare diseases; flexible study designs that accelerate development programs and deliver high approval ratings that are among the best in the industry; and exceptional global project management and gold standard safety and data management systems that strengthen their program’s success potential. Established in 1999 and headquartered in Cincinnati, OH; CTI has offices in North America, Europe and South America.

Original Press Release

Subscribe to our mailing list

* indicates required